POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,292,649 | +44.0% | 543,130 | +6.5% | 0.00% | – |
| Q2 2023 | $897,528 | +180.8% | 509,959 | +391.4% | 0.00% | – |
| Q1 2023 | $319,603 | -29.4% | 103,767 | +21.4% | 0.00% | – |
| Q4 2022 | $452,970 | +96.1% | 85,466 | +31.1% | 0.00% | – |
| Q3 2022 | $231,000 | +79.1% | 65,168 | +29.7% | 0.00% | – |
| Q2 2022 | $129,000 | -88.0% | 50,246 | -79.0% | 0.00% | – |
| Q1 2022 | $1,072,000 | -37.5% | 239,289 | -5.0% | 0.00% | – |
| Q4 2021 | $1,715,000 | -8.5% | 251,793 | -2.0% | 0.00% | – |
| Q3 2021 | $1,874,000 | -23.7% | 257,061 | +4.9% | 0.00% | – |
| Q2 2021 | $2,456,000 | +55.4% | 245,069 | +48.1% | 0.00% | – |
| Q1 2021 | $1,580,000 | -11.2% | 165,425 | +2.0% | 0.00% | – |
| Q4 2020 | $1,780,000 | +19.7% | 162,195 | -3.2% | 0.00% | – |
| Q3 2020 | $1,487,000 | – | 167,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |